115 related articles for article (PubMed ID: 8897436)
1. Botulinum neurotoxins: mechanism of action and therapeutic applications.
Montecucco C; Schiavo G; Tugnoli V; de Grandis D
Mol Med Today; 1996 Oct; 2(10):418-24. PubMed ID: 8897436
[TBL] [Abstract][Full Text] [Related]
2. From Toxin to Treatment: A Narrative Review on the Use of Botulinum Toxin for Autonomic Dysfunction.
Rempel L; Malik RN; Shackleton C; Calderón-Juárez M; Sachdeva R; Krassioukov AV
Toxins (Basel); 2024 Feb; 16(2):. PubMed ID: 38393175
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin: bioweapon & magic drug.
Dhaked RK; Singh MK; Singh P; Gupta P
Indian J Med Res; 2010 Nov; 132(5):489-503. PubMed ID: 21149997
[TBL] [Abstract][Full Text] [Related]
4. Botulinum neurotoxin: A therapeutic powerhouse with broad clinical implications.
Aldridge JHR
JAAPA; 2023 Apr; 36(4):39-41. PubMed ID: 36976032
[TBL] [Abstract][Full Text] [Related]
5. Neurotoxins Acting at Synaptic Sites: A Brief Review on Mechanisms and Clinical Applications.
Zhou K; Luo W; Liu T; Ni Y; Qin Z
Toxins (Basel); 2022 Dec; 15(1):. PubMed ID: 36668838
[TBL] [Abstract][Full Text] [Related]
6. The story of Clostridium botulinum: from food poisoning to Botox.
Ting PT; Freiman A
Clin Med (Lond); 2004; 4(3):258-61. PubMed ID: 15244362
[TBL] [Abstract][Full Text] [Related]
7. Clostridial neurotoxins: structure-function led design of new therapeutics.
Chaddock JA; Marks PM
Cell Mol Life Sci; 2006 Mar; 63(5):540-51. PubMed ID: 16416025
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin as a carrier for oral vaccines.
Simpson LL; Maksymowych AB; Kiyatkin N
Cell Mol Life Sci; 1999 Oct; 56(1-2):47-61. PubMed ID: 11213260
[TBL] [Abstract][Full Text] [Related]
9. Introduction to the
Luvisetto S
Toxins (Basel); 2023 Sep; 15(9):. PubMed ID: 37755966
[TBL] [Abstract][Full Text] [Related]
10. Recent Developments in Engineering Non-Paralytic Botulinum Molecules for Therapeutic Applications.
Zhantleuova A; Leese C; Andreou AP; Karimova A; Carpenter G; Davletov B
Toxins (Basel); 2024 Apr; 16(4):. PubMed ID: 38668600
[TBL] [Abstract][Full Text] [Related]
11. Botulinum Neurotoxins: From Toxin to Medicine.
Santamato A
Toxins (Basel); 2023 Oct; 15(10):. PubMed ID: 37888652
[TBL] [Abstract][Full Text] [Related]
12. Preclinical Evidence for the Role of Botulinum Neurotoxin A (BoNT/A) in the Treatment of Peripheral Nerve Injury.
Adler M; Pellett S; Sharma SK; Lebeda FJ; Dembek ZF; Mahan MA
Microorganisms; 2022 Apr; 10(5):. PubMed ID: 35630331
[TBL] [Abstract][Full Text] [Related]
13. Emerging Opportunities in Human Pluripotent Stem-Cells Based Assays to Explore the Diversity of Botulinum Neurotoxins as Future Therapeutics.
Duchesne de Lamotte J; Perrier A; Martinat C; Nicoleau C
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299143
[TBL] [Abstract][Full Text] [Related]
14. Obesity and Atrial Fibrillation: Epidemiology, Pathophysiology and Novel Therapeutic Opportunities.
Vyas V; Lambiase P
Arrhythm Electrophysiol Rev; 2019 Mar; 8(1):28-36. PubMed ID: 30918664
[TBL] [Abstract][Full Text] [Related]
15. Botulinum Neurotoxin Light Chains Expressed by Defective Herpes Simplex Virus Type-1 Vectors Cleave SNARE Proteins and Inhibit CGRP Release in Rat Sensory Neurons.
Joussain C; Le Coz O; Pichugin A; Marconi P; Lim F; Sicurella M; Salonia A; Montorsi F; Wandosell F; Foster K; Giuliano F; Epstein AL; Aranda Muñoz A
Toxins (Basel); 2019 Feb; 11(2):. PubMed ID: 30791373
[TBL] [Abstract][Full Text] [Related]
16. Temporary Suppression of Cardiac Ganglionated Plexi Leads to Long-Term Suppression of Atrial Fibrillation: Evidence of Early Autonomic Intervention to Break the Vicious Cycle of "AF Begets AF".
Lo LW; Chang HY; Scherlag BJ; Lin YJ; Chou YH; Lin WL; Chen SA; Po SS
J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27381759
[TBL] [Abstract][Full Text] [Related]
17. Botulinum neurotoxin for pain management: insights from animal models.
Pavone F; Luvisetto S
Toxins (Basel); 2010 Dec; 2(12):2890-913. PubMed ID: 22069581
[TBL] [Abstract][Full Text] [Related]
18. Sacral neuromodulation: Therapy evolution.
Thompson JH; Sutherland SE; Siegel SW
Indian J Urol; 2010 Jul; 26(3):379-84. PubMed ID: 21116359
[TBL] [Abstract][Full Text] [Related]
19. Short-term autonomic denervation of the atria using botulinum toxin.
Oh S; Choi EK; Choi YS
Korean Circ J; 2010 Aug; 40(8):387-90. PubMed ID: 20830252
[TBL] [Abstract][Full Text] [Related]
20. Refractory overactive bladder: Beyond oral anticholinergic therapy.
Glinski RW; Siegel S
Indian J Urol; 2007 Apr; 23(2):166-73. PubMed ID: 19675795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
